Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Octagon shuts down after R&D challenges put it behind the 8 ball
The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead asset and running into unresolved biology questions.
Nick Paul Taylor
Apr 29, 2025 7:40am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Novo inks $1B deal for Lexicon’s preclinical obesity prospect
Mar 28, 2025 7:30am
Cell and gene company ElevateBio lays off 17% of staff
Mar 26, 2025 1:08pm
Novo pens $2B deal for triple agonist weight loss drug
Mar 24, 2025 9:50am
